The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-Ctla4 Agents: The Growing Role of the Dermatologist in the Management of Patients With Metastatic Melanoma
Current Dermatology Reports - United States
doi 10.1007/s13671-013-0039-9
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 5, 2013
Authors
Publisher
Springer Science and Business Media LLC